Skip to main content
  • Home
  • News
  • MAA Covid-19 Vaccination Announcement

MAA Covid-19 Vaccination Announcement

MAA Covid-19 Vaccination Announcement

Posted on Tuesday, January 04 2022

Dr Stephen Reddel would like to draw attention to the announcement made by ATAGI in regard to a booster Covid Vaccination for people who receive immune-suppressing treatment.

He writes - Please be aware of the statement 24.12.2021 from the Australian Technical Advisory Group on Immunisation (ATAGI) about the COVID-19 Omicron variant and the timing of COVID-19 booster vaccination, here: 
Of particular note, patients who are immunocompromised, including some of the medications used for conditions such as Myasthenia Gravis, are now recommended to have three primary vaccination doses plus a fourth dose booster ideally at 3 months after the third primary dose. 

Dr Reddel summarises by saying - “For clarity, this means the initial two doses at the recommended interval for that vaccine, then a third primary dose (previously known as a booster) 2 months later either Pfizer or Moderna, then a 4th booster dose ideally 3 months after the 3rd dose, again either Pfizer or Moderna." 

Please note that this information may be useful for patients and their treating doctors but does not constitute medical advice.


MessaGes Mailing List

Enter your details below to receive our monthly MessaGes Newsletter and upcoming News and Events directly to your Email inbox.